Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.16 - $6.41 $535,916 - $2.96 Million
461,997 Added 550.38%
545,939 $633,000
Q4 2022

Feb 13, 2023

SELL
$4.78 - $15.01 $1.54 Million - $4.85 Million
-323,197 Reduced 79.38%
83,942 $443,000
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $4.16 Million - $9.65 Million
407,139 New
407,139 $4.69 Million
Q2 2022

Aug 12, 2022

SELL
$4.35 - $15.85 $786,044 - $2.86 Million
-180,700 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$4.55 - $6.41 $315,451 - $444,405
69,330 Added 62.25%
180,700 $873,000
Q4 2021

Feb 11, 2022

BUY
$5.89 - $9.73 $210,002 - $346,913
35,654 Added 47.09%
111,370 $656,000
Q3 2021

Nov 12, 2021

SELL
$6.78 - $9.89 $2.37 Million - $3.46 Million
-349,384 Reduced 82.19%
75,716 $646,000
Q2 2021

Aug 13, 2021

SELL
$7.24 - $11.2 $876,764 - $1.36 Million
-121,100 Reduced 22.17%
425,100 $3.43 Million
Q1 2021

May 13, 2021

BUY
$8.05 - $20.78 $4.23 Million - $10.9 Million
524,906 Added 2465.04%
546,200 $5.89 Million
Q4 2020

Feb 10, 2021

SELL
$2.36 - $9.99 $978,201 - $4.14 Million
-414,492 Reduced 95.11%
21,294 $184,000
Q3 2020

Nov 13, 2020

SELL
$2.58 - $3.36 $2.34 Million - $3.05 Million
-907,900 Reduced 67.57%
435,786 $1.14 Million
Q2 2020

Aug 13, 2020

BUY
$3.01 - $4.02 $566,181 - $756,161
188,100 Added 16.28%
1,343,686 $4.49 Million
Q1 2020

May 14, 2020

BUY
$2.58 - $4.58 $651,901 - $1.16 Million
252,675 Added 27.98%
1,155,586 $3.78 Million
Q4 2019

Feb 13, 2020

BUY
$1.86 - $3.35 $944,132 - $1.7 Million
507,598 Added 128.4%
902,911 $3.03 Million
Q3 2019

Nov 13, 2019

BUY
$1.81 - $2.36 $241,006 - $314,241
133,153 Added 50.79%
395,313 $854,000
Q2 2019

Aug 12, 2019

BUY
$1.26 - $2.14 $213,633 - $362,837
169,550 Added 183.08%
262,160 $558,000
Q1 2019

May 14, 2019

BUY
$1.2 - $1.59 $36,372 - $48,192
30,310 Added 48.65%
92,610 $135,000
Q4 2018

Feb 13, 2019

BUY
$1.21 - $1.54 $75,383 - $95,942
62,300 New
62,300 $87,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.